VT
ABBV icon

Vise Technologies’s AbbVie ABBV Stock Holding History

Vise Technologies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Hold
68,156
– – 0.31% 60
2025
Q4 		$15.6M Buy
68,156
+25,198
+59% +$5.74M 0.31% 60
2025
Q3 		$9.95M Sell
42,958
-3,454
-7% -$703K 0.37% 54
2025
Q2 		$8.62M Buy
+46,412
New +$8.63M 0.36% 50
2024
Q4 		$4.67M Buy
26,275
+5,830
+29% +$1.07M 0.39% 48
2024
Q3 		$4.04M Buy
20,445
+3,123
+18% +$583K 0.51% 41
2024
Q2 		$2.97M Buy
17,322
+1,641
+10% +$272K 0.52% 41
2024
Q1 		$2.86M Sell
15,681
-344
-2% -$59.3K 0.56% 42
2023
Q4 		$2.48M Sell
16,025
-1,269
-7% -$185K 0.53% 45
2023
Q3 		$2.58M Buy
17,294
+3,099
+22% +$455K 0.63% 38
2023
Q2 		$1.91M Sell
14,195
-985
-6% -$144K 0.46% 45
2023
Q1 		$2.42M Buy
15,180
+3,846
+34% +$588K 0.64% 37
2022
Q4 		$1.83M Sell
11,334
-26
-0.2% -$3.99K 0.57% 39
2022
Q3 		$1.52M Buy
11,360
+5,718
+101% +$821K 0.57% 38
2022
Q2 		$864K Buy
5,642
+2,819
+100% +$431K 0.34% 66
2022
Q1 		$458K Buy
+2,823
New +$410K 0.17% 132

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vise Technologies's ABBV Position: Q1 2026 in Review

Vise Technologies held its AbbVie (ABBV) position steady in Q1 2026 at 68,156 shares worth $15.6M. The position accounts for 0.31% of the portfolio, ranked #60.

Vise Technologies first reported a position in ABBV in Q1 2022 and has held it in 16 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vise Technologies held 68,156 shares of AbbVie worth $15.6M as of Q1 2026.
  • Vise Technologies left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.31% of Vise Technologies's portfolio in Q1 2026, its #60 holding.
  • Vise Technologies first reported a position in AbbVie in Q1 2022 and has held it in 16 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.